Source: International Congress 2016 – Chronic graft-versus-host disease and chronic allograft dysfunction after lung transplantation: similarities and dissimilarities
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Robin Vos (Leuven, Belgium). Treatment options in chronic GVHD and CLAD post lung transplantation. International Congress 2016 – Chronic graft-versus-host disease and chronic allograft dysfunction after lung transplantation: similarities and dissimilarities

Member's Comments

No comment yet.

Related content which might interest you: Dichotomy in pulmonary graft-versus-host disease evident among allogeneic stem-cell transplant recipients undergoing lung transplantation Source: Eur Respir J 2016; 48: 1807-1810 Year: 2016 Evaluation of lung mechanics and the progression of disease in acute allograft rejection after lung transplantation Source: Annual Congress 2010 - New clinical and experimental insights in lung transplantation Year: 2010 Lung transplantation in rare lung diseases: the problem of chronic lung allograft dysfunction (CLAD) Source: International Congress 2018 – Rare lung diseases Year: 2018 Pulmonary graft-versus-host disease (GVHD) post- stem cell transplant (SCT) for haematological malignancies: Good response to treatment if diagnosed early Source: Annual Congress 2012 - Diffuse parenchymal lung disease I Year: 2012 Efficacy of tacrolimus rescue therapy in refractory acute rejection (AR) after lung transplantation Source: Eur Respir J 2001; 18: Suppl. 33, 298s Year: 2001 Assessment of the restrictive allograft syndrome in patients after lung transplantation Source: Annual Congress 2012 - Lung transplantation: studies in candidates and recipients Year: 2012 Orthotopic lung transplantation in a single-mismatch-based mouse model shows signs of chronic lung allograft dyfunction (CLAD) Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside Year: 2016 Multiple breath washout can facilitate the diagnosis of lung graft-versus-host disease in children after allogeneic hematopoietic stem cell transplantation Source: International Congress 2016 – Insights into the pathophysiology of childhood lung disease Year: 2016 Lung transplantation: the ideal treatment for diffuse disease? Source: Annual Congress 2006 - Up to date management of bronchiectasis Year: 2006 A model of chronic lung allograft rejection in the rat Source: Eur Respir J 2010; 35: 1354-1363 Year: 2010 Aerosolized liposomal cyclosporine A for treatment of progressive allograft dysfunction following lung transplantation Source: Annual Congress 2013 –Clinical studies in lung transplantation Year: 2013 Early sirolimus immunosuppression is safe in lung transplantation Source: Annual Congress 2012 - Optimising outcomes after lung transplantation Year: 2012 Noninfectious infiltrative lung diseases after allogeneic hematopoïetic stem cell transplantation (HSCT) Source: Annual Congress 2013 –Diffuse parenchymal lung disease I Year: 2013 The murine orthotopic single lung transplantation model for chronic rejection: work in progress? Source: International Congress 2018 – Lung transplant science: from primary graft to chronic allograft dysfunction Year: 2018 Fludarabine in paediatric steroid-refractory inflammatory lung injury after stem cell transplantation Source: Eur Respir J 2013; 41: 479-483 Year: 2013 Better survival outcomes after bilateral lung transplantation compared to single lung transplantation in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Clinical studies in lung transplantation Year: 2013 Rapamycin in patients with chronic lung rejection Source: Eur Respir J 2005; 26: Suppl. 49, 635s Year: 2005 Current status of lung transplantation Source: Eur Respir J 2003; 22: 57S-64S Year: 2003 Infectious complications after lung transplantation Source: ISSN=1025-448x, ISBN=1-904097-29-4, page=193 Year: 2003 Medical complications of lung transplantation Source: Eur Respir J 2004; 23: 334-342 Year: 2004